IL6R and peripheral arterial disease: Furthermore, elevated levels of the IL-6 receptor, in either its membrane-bound form (IL6R) or soluble form (sIL6R), have been linked to a reduced risk of PAD, suggesting that genetic variants promoting these effects confer a protective profile [41].